Susan G. Komen, Cancer Australia to Co-fund Metastatic BC Research
A new partnership between Susan G. Komen and Cancer Australia will grant a researcher $450,000 over three years to study metastatic breast cancer. Through ... Read more
Updates
-
News Susan G. Komen, Cancer Australia to Co-fund Metastatic BC Research
-
News Combining 2 Assessments of Breast Cancer Recurrence Risk May Help Guide Use of Adjuvant Chemotherapy
-
A Lump in the Road - A Column by Nancy Brier, Columns How a $100 Bill Brings Me Peace of Mind
-
News Long-term Data Continue to Support Perjeta Regimen for HER2-positive Metastatic Breast Cancer
-
News New AI-based Model Outperforms Current Methods of Predicting Breast Cancer Risk
-
News Chemo Resistance in TNBC Due to Molecular Changes That May Be Treatable, Study Suggests
-
News Prestige’s HD201, a Biosimilar to Herceptin, Accepted for Review in Europe for HER2-positive BC
-
News FDA Approves Piqray-Faslodex Combo for Some Patients with Advanced Breast Cancer
-
A Lump in the Road - A Column by Nancy Brier, Columns The Blonde in the Waiting Room
-
News Keytruda Fails to Improve Overall Survival of Patients with Triple-Negative Breast Cancer, Phase 3 Trial Shows
-
News Treatment Intensity Should Be Personalized in Women with HER2-positive Breast Cancer, Study Says
-
News Young Women More Likely to Face Aggressive BC Types, But Proper Treatment Improves Outcomes
-
News Experimental Antibody Therapy Leads to Significant Responses in HER2-positive Breast Cancer, Phase 2 Trial Shows
-
A Lump in the Road - A Column by Nancy Brier, Columns Here I Am
-
News Radiation Therapy Reduces Chances of Breast Cancer Returning in Women with Early, Hormone-Positive Disease, Trial Shows
-
News Kadcyla Approved in US for Some HER2-positive Early Breast Cancer Patients
-
News SHARE Introduces My MBC & Me App for Metastatic Breast Cancer Patients
-
News New Imaging Tool Captures Process That Turns Tumor Cells Malignant in Breast Cancer
-
A Lump in the Road - A Column by Nancy Brier, Columns Walking on Broken Glass
-
News Clinical Trial Will Test Investigational Therapy Targeting ‘Dormant’ Breast Cancer Cells
-
News Surgery That Removes All Traces of Breast Cancer Stimulates Protective Anticancer Immune Response, Mouse Study Suggests
-
News Liposomal Irinotecan Shows Promising Phase 1 Results in Heavily Treated Breast Cancer Patients
-
News Antibiotic in Long Use for Leprosy, Clofazimine, May Treat Triple-negative Breast Cancer, Mouse Study Suggests
-
News AstraZeneca Teams with Daiichi Sankyo to Speed Development of HER2-positive Advanced Breast Cancer Therapy
-
A Lump in the Road - A Column by Nancy Brier, Columns It’s Probably Nothing
-
News Lynparza Approved in EU to Treat Subset of Advanced Breast Cancer
-
News Surgery Extends Lives of Women with Metastatic Breast Cancer, Study Says
-
News FDA Approves Ibrance Combo Therapy for Some Male Breast Cancers
-
News Time-Restricted Feeding May Cut Tumor Risk in Obese Women, Mouse Study Suggests
-
News Faslodex-Arimidex Improves Survival in Post-menopausal Women with Advanced BC, Trial Shows
-
News FDA Proposes New Policies to Modernize, Improve Quality of Mammography Screenings
-
A Lump in the Road - A Column by Nancy Brier, Columns Doc, You’re a Downer. Let Me Revel in My 5-Year Mark
-
News Breast Cancer Survivors Weigh in on Ways to Reduce the Financial Burden of the Disease
-
News Frying Oil Reheated Often, Like in Deep Frying, Seen to Promote Breast Cancer’s Spread in Animal Study
-
News Molecular Patterns of Breast Cancer May Predict Chance of Relapse Up to 20 Years Later
-
News Estrogen May Trigger Brain Metastasis in Triple-negative Breast Cancer, Study Shows
-
News AI Matches Radiologists’ Skill at Detecting Breast Cancer on Mammograms
-
News CHMP Favors EU Approval of Lynparza for Some Advanced Breast Cancers
-
A Lump in the Road - A Column by Nancy Brier, Columns Reaching the Double Nickel
-
News Vitamin C Might Reverse Stress-induced Driver of Breast Cancer, Study Says
-
News FDA Grants Accelerated Approval to Tecentriq-Abraxane Combo for Some TNBC
-
News Thousands of Lives Spared Thanks to Screening, Treatment, Study Reports
-
News NeuVax/Herceptin Combo Promotes Disease-free Survival in TNBC
-
News FDA Approves Under-the-skin Formulation of Herceptin for Certain Breast Cancers
-
News Imaging Agent May Provide Early Info About Benefits of Hormone Therapies for Breast Cancer
-
A Lump in the Road - A Column by Nancy Brier, Columns How to Tell Your Kid You Have Cancer: 7 Tips
-
News Cellular Barcoding Sheds Light on Spread, Drug Resistance of TNBC
-
News Pfizer’s Biosimilar Zirabev Approved in E.U. for Advanced Breast, Other Cancers
-
News Sacituzumab Govitecan Shinks Tumors in One of Three Metastatic TNBC Patients, Trial Shows
-
A Lump in the Road - A Column by Nancy Brier, Columns Fingers on My Breasts and Questions on My Mind
-
News More Intense Chemotherapy May Lower Risk of Breast Cancer Recurrence and Death, Study Says
-
News Plerixafor Improves Immunotherapy Response in Mouse Model of Breast Cancer
-
News Young Survival Coalition Hosts Summit for BC Survivors, Supporters
-
News Experimental Compound Could Broaden HER2-targeted Approach to BC
-
News Changes in Gene Expression May Hint at Relapse Risk in ER-positive Patients on Hormone Therapy, Study Finds
-
A Lump in the Road - A Column by Nancy Brier, Columns The Luck of the Draw
-
News Margetuximab Helps to Delay Disease Progression in Advanced, HER2-positive Breast Cancers, Phase 3 Trial Shows
-
News FDA to Review Kadcyla for Certain HER2-positive Early-stage Breast Cancer Patients
-
News Knight Therapeutics Acquires Exclusive Marketing Rights to Nerlynx in Canada
-
News Breast Cancers Diagnosed Within 10 Years of Pregnancy Have Higher Risk of Metastasis, Study Shows
-
News Blocking Interaction Between Blood Vessels, Cancer Cells Could Prevent Disease’s Spread, Study Says
-
News Mathematical Model Calculates Breast Cancer Risk in Women
-
A Lump in the Road - A Column by Nancy Brier, Columns Teaching an Old Drug New Tricks: Ketamine and Depression
-
News Breast Cancer Cells Can Be Turned into Harmless Fat Cells in Mice, Study Shows
-
News FDA Wants More Data Before Sacituzumab Govitecan Is Approved for Metastatic Triple-negative Breast Cancer
-
News Tinagl1 Protein Suppresses Triple-negative Breast Cancer Development in Mouse Study
-
News Phase 3 Trial of Oraxol for Metastatic Breast Cancer Is Fully Enrolled
-
News Insight Into How Breast Cancers Evade Immune System Could Help in Developing Therapies, Study Says
-
News Breast Cancer Risk Appears to Be Higher in Women Who Have Had Babies, Study Shows
-
News Phase 1b/2 Trial Testing Rebastinib/Chemo Combo in Advanced Cancer Patients Begins
-
News Partial Breast Radiation Therapy May Effectively Prevent Cancer Relapse, Trial Shows
-
News FDA OKs Phase 2 Trial of AE37-Keytruda Combo in Metastatic Triple-negative Breast Cancer
-
A Lump in the Road - A Column by Nancy Brier, Columns Short, Striped, and Revealing: The Worst New Year’s Eve Dress Ever
-
News Circulating Tumor Cell Numbers May Help Decide Best Therapy for Metastatic Breast Cancer, Phase 3 Trial Shows
-
News Phase 3 Trial of Sacituzumab Govitecan Recruiting Triple-negative Breast Cancer Patients
-
News Study Reveals a Weakness of Breast Cancer Bone Metastasis
-
A Lump in the Road - A Column by Nancy Brier, Columns Breast Cancer Stole My Bling
-
News Enrollment Complete in Phase 2 Trial of NeuVax-Herceptin for HER2-Positive, High-Risk Breast Cancer
-
News Couple Share $1.8 Million to Test More Precise Image-guided Breast Radiation Therapy
-
News Phase 1/2 Trial Testing Combo of Bria-IMT and Immune Checkpoint Inhibitors Begins Dosing Breast Cancer Patients
-
News J. Lohr Vineyards Marks 10 Years of Supporting the National Breast Cancer Foundation
-
A Lump in the Road - A Column by Nancy Brier, Columns Yeah, Doctor. I’m Talking to You
-
News Planned Phase 2 Trial to Test Vaccine in Triple-negative Breast Cancer Patients, Generex Says
-
News 2 Trials, Now Enrolling, Aimed at Improving Breast Cancer Prevention, Diagnosis, and Treatment
-
News Tecentriq-Chemo Combo Under FDA Review as First-line Therapy for PD-L1-positive, Metastatic Triple-negative Breast Cancer
-
A Lump in the Road - A Column by Nancy Brier, Columns We May Not Think About It, but Trusting the Process Is Important
-
News DoD Awards $11M for Phase 2 Trial of TPIV110 Breast Cancer Therapy
-
A Lump in the Road - A Column by Nancy Brier, Columns Gary Buys a Sandwich
-
News Early-stage Breast Cancer Patients Failing to Use to Hormone Therapy Long-term, French Study Finds
-
News Researchers Develop ‘Bio-patch’ to Monitor Post-surgical Success of Breast Reconstruction
-
News Phase 2 Trial to Test Keytruda, Tomivosertib Combo in Triple-negative Breast Cancers
-
A Lump in the Road - A Column by Nancy Brier, Columns The Dodgers, the Statue of Liberty, Breast Cancer, and Me
-
News Ibrance-Faslodex Combo Improves Survival of Advanced Breast Cancer Patients, Phase 3 Trial Shows
-
News Processed Meat Consumption Linked to Higher Breast Cancer Risk, Review Study Shows
-
A Lump in the Road - A Column by Nancy Brier, Columns Paint the Parking Spot Pink
-
News Therapies Given to Women with Advanced Breast Cancer Equally Effective and Safe in Men, Studies Report
-
News Tecentriq-Abraxane Prolongs Survival of Advanced Triple-negative Breast Cancer Patients, Study Shows
-
News Sermonix Launches Phase 2 Trial Testing Lasofoxifene in Advanced Breast Cancer Patients with ER Mutations
-
A Lump in the Road - A Column by Nancy Brier, Columns I Wouldn’t Give My Right Arm
-
-
Combining 2 Assessments of Breast Cancer Recurrence Risk May Help Guide Use of Adjuvant Chemotherapy
Adding an assessment of a woman’s clinical risk to Genomic Health‘s genomic test Oncotype DX to estimate the likelihood of breast cancer recurrence may ... Read more -
How a $100 Bill Brings Me Peace of Mind
I could smell cleanliness when I opened my front door. Lemon. Pine. The glorious absence of dust. It’s that elusive moment right after my ... Read more -
Long-term Data Continue to Support Perjeta Regimen for HER2-positive Metastatic Breast Cancer
End-of-study data from the CLEOPATRA trial supports the long-term efficacy of Genentech‘s Perjeta (pertuzumab) plus Herceptin (trastuzumab) and docetaxel chemotherapy for patients with previously ... Read more -
New AI-based Model Outperforms Current Methods of Predicting Breast Cancer Risk
Scientists have created a new artificial intelligence (AI)-based model that outperforms current models at predicting the risks a woman has of developing breast cancer, ... Read more
-
Chemo Resistance in TNBC Due to Molecular Changes That May Be Treatable, Study Suggests
Triple-negative breast cancer (TNBC) cells can become resistant to chemotherapy by temporarily turning on ... -
Prestige’s HD201, a Biosimilar to Herceptin, Accepted for Review in Europe for HER2-positive BC
The European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) ... -
FDA Approves Piqray-Faslodex Combo for Some Patients with Advanced Breast Cancer
Breast cancer patients in the U.S. who are receptor positive (HR+), human epidermal growth ... -
The Blonde in the Waiting Room
A young woman weeped. Pretty blond hair swung in front of her face, but ... -
Keytruda Fails to Improve Overall Survival of Patients with Triple-Negative Breast Cancer, Phase 3 Trial Shows
Keytruda (pembrolizumab), Merck‘s anti-PD-1 checkpoint blockade immunotherapy, failed to prolong the overall survival of ... -
Treatment Intensity Should Be Personalized in Women with HER2-positive Breast Cancer, Study Says
Personalized treatment intensity is crucial to the success of less toxic and demanding therapies ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
-
Young Women More Likely to Face Aggressive BC Types, But Proper Treatment Improves Outcomes
Young women are more likely than older ones to be diagnosed with more aggressive ... -
Experimental Antibody Therapy Leads to Significant Responses in HER2-positive Breast Cancer, Phase 2 Trial Shows
Trastuzumab deruxtecan (DS-8201), an investigational antibody-drug conjugate developed by AstraZeneca with Daiicho Sankyo, led ... -
-
-
-
-
New Imaging Tool Captures Process That Turns Tumor Cells Malignant in Breast Cancer
A new imaging technique that visualizes individual cells with high resolution may improve the ... -
-
-
-
Liposomal Irinotecan Shows Promising Phase 1 Results in Heavily Treated Breast Cancer Patients
Treatment with a liposomal formulation of irinotecan — meaning the chemotherapy is wrapped up ... -
-
-
-
Lynparza Approved in EU to Treat Subset of Advanced Breast Cancer
Lynparza (olaparib) tablets have been approved by the European Commission as a standalone treatment ... -
Surgery Extends Lives of Women with Metastatic Breast Cancer, Study Says
Women with HER2-positive breast cancer that has spread to distant organs live longer if ... -
FDA Approves Ibrance Combo Therapy for Some Male Breast Cancers
The U.S. Food and Drug Administration (FDA) has expanded the use of Ibrance (palbociclib) capsules ... -
Time-Restricted Feeding May Cut Tumor Risk in Obese Women, Mouse Study Suggests
A preliminary study in mice suggests that when a person eats, and not what ... -
Faslodex-Arimidex Improves Survival in Post-menopausal Women with Advanced BC, Trial Shows
First-line treatment with Arimidex (anastrozole) plus Faslodex (fulvestrant) prolongs the lives of post-menopausal women ... -
FDA Proposes New Policies to Modernize, Improve Quality of Mammography Screenings
The U.S. Food and Drug Administration (FDA) has proposed a set of new policies ... -
Doc, You’re a Downer. Let Me Revel in My 5-Year Mark
I met a guy at a party. At first, he was quite the charmer, ... -
Breast Cancer Survivors Weigh in on Ways to Reduce the Financial Burden of the Disease
A qualitative study has proposed nine recommendations from breast cancer survivors about how to ... -
Frying Oil Reheated Often, Like in Deep Frying, Seen to Promote Breast Cancer’s Spread in Animal Study
Frying oil that has repeatedly been reheated to high temperatures — as can take ... -
Molecular Patterns of Breast Cancer May Predict Chance of Relapse Up to 20 Years Later
Screening a woman’s breast cancer for certain genetic and molecular patterns may be used ... -
Estrogen May Trigger Brain Metastasis in Triple-negative Breast Cancer, Study Shows
Estradiol, a type of estrogen and the major female hormone, may drive the spread ... -
AI Matches Radiologists’ Skill at Detecting Breast Cancer on Mammograms
An artificial intelligence (AI) system based on deep learning algorithms is able to detect ... -
CHMP Favors EU Approval of Lynparza for Some Advanced Breast Cancers
The Committee for Medicinal Products for Human Use (CHMP), an arm of the European Medicines ... -
Reaching the Double Nickel
I shivered in the parking lot at my kid’s school with four other moms. ... -
Vitamin C Might Reverse Stress-induced Driver of Breast Cancer, Study Says
Chronic stress and the consequent release of the stress hormone epinephrine may help breast ... -
FDA Grants Accelerated Approval to Tecentriq-Abraxane Combo for Some TNBC
The U.S. Food and Drug Administration has granted accelerated approval to a combination of ... -
Thousands of Lives Spared Thanks to Screening, Treatment, Study Reports
Since 1989, between 384,000 and 615,000 women’s lives have been spared thanks to significant ...
Clinical Trial of Tamoxifen-based Gel in Reducing Breast Density Recruiting in US, EU
News
The ability of a gel containing a tamoxifen-byproduct to reduce breast density — associated with an increased risk of breast cancer — is now being evaluated in a recruiting Phase 3 clinical trial. Approximately half of women in ... Read more